Reuven B. Young

Davis Polk is advising the joint-bookrunners to Electrocomponents plc on its placing of 21,518,181 million new ordinary shares at 825 pence per share. Concurrently with the placing, retail…

Davis Polk advised the dealer managers in connection with cash tender offers by Commonwealth Bank of Australia to purchase certain of its outstanding debt securities. Headquartered in…

Davis Polk advised the initial purchasers in connection with a Rule 144A/Regulation S offering by Prosus N.V. of $1.5 billion principal amount of 3.832% notes due 2051 under its $6 billion…

Davis Polk advised the joint book-running managers in connection with a Rule 144A / Regulation S offering of $500 million aggregate principal amount of 1.729% senior notes due 2030 by…

Davis Polk advised HusCompagniet A/S on the initial public offering of 9,600,000 existing ordinary shares (excluding any overallotment option shares) sold by HusCompagniet’s shareholders,…

Davis Polk advised NatWest Group plc, a public limited company incorporated under the laws of Scotland, in connection with its SEC-registered shelf takedown of £1 billion aggregate…

Davis Polk advised the underwriters in connection with an SEC-registered offering of $700 million aggregate principal amount of 3.750% notes due 2030 by AngloGold Ashanti Holdings plc,…

Davis Polk advised Delek Overriding Royalty Leviathan Ltd., on its Rule 144A offering of $180 million principal amount of 7.494% senior secured notes due 2023. The notes are secured by…

Davis Polk advised Xspray Pharma AB (publ) on a private placing of new shares. The private placing raised gross proceeds of approximately SEK 265 million.  Xspray was founded in 2003…

Davis Polk advised Smith & Nephew plc in connection with the establishment of a WKSI shelf and its debut SEC-registered shelf takedown of $1 billion aggregate principal amount of 2.032%…